C-Path's Transplant Therapeutics Consortium (TTC), ASTS, and the American Society of Transplantation (AST) are pleased to announce the first-ever recipients of the TTC Data Trailblazer Award.
The ASTS Diversity Issues Committee is accepting applications for a funded opportunity to become a Health Disparities Research Education Program (HDREP) Scholar.
Critical Path Institute (C-Path) announced today that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the Composite Biomarker Panel (iBox Scoring System) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).
In addition to the COVID-19 crisis, our country is now hurting in a very different way. The very city we were to be gathered in for this year’s ATC and many others around the country have erupted with demonstrations in the wake of George Floyd’s death.
American Journal of Transplantation invites applications for the Editorial Fellowship Program, which offers a year-long editorial experience in the publication and peer review process to fellows and junior faculty in transplant-related fields.